4//SEC Filing
Lavelle Erin 4
Accession 0001209191-22-005659
CIK 0001768446other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:16 PM ET
Size
5.5 KB
Accession
0001209191-22-005659
Insider Transaction Report
Form 4
Lavelle Erin
COO & CFO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+170,000→ 170,000 totalExercise: $8.21Exp: 2032-01-26→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/48th of the shares will vest on each monthly anniversary of January 27, 2022.
Documents
Issuer
Eliem Therapeutics, Inc.
CIK 0001768446
Entity typeother
Related Parties
1- filerCIK 0001737613
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:16 PM ET
- Size
- 5.5 KB